SCHEMBL13615820

SCHEMBL13615820

C[Si](C)(C)c1ccc(-c2ccc3c4ccccc4c4c5cc(-c6ccc([Si](C)(C)C)cc6)ccc5c5ccccc5c4c3c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRIM58 Q8NG06 1/20 0.35
JAK2 O60674 2/20 0.32
PLA2G2A P14555 1/20 0.31
PLA2G4A P47712 1/20 0.31
SCN5A Q14524 1/20 0.31
GAA P10253 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
DHFR P00374 1/20 0.31
MAP4K4 O95819 1/20 0.31
CCNE2 O96020 1/20 0.31
CDK4 P11802 1/20 0.31
CCND1 P24385 1/20 0.31
CCNE1 P24864 1/20 0.31
CDK2 P24941 1/20 0.31
ALDH1A1 P00352 1/20 0.30
CYP1A2 P05177 1/20 0.30
THRB P10828 1/20 0.30
HPGD P15428 1/20 0.30
HSD17B10 Q99714 1/20 0.30
TNKS2 Q9H2K2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13615927 0.84 CYP1A2 (0.34) ALDH1A1CYP1A2THRBHPGDHSD17B10
SCHEMBL13615895 0.84 CYP1A2 (0.34) ALDH1A1CYP1A2THRBHPGDHSD17B10
SCHEMBL13615738 0.84 CYP1A2 (0.34) ALDH1A1CYP1A2THRBHPGDHSD17B10
SCHEMBL13615829 0.81 JAK2 (0.35) TRIM58JAK2PLA2G2APLA2G4ADHFR
SCHEMBL24702946 0.79 TRIM58 (0.40) TRIM58JAK2PLA2G2APLA2G4AGAA
SCHEMBL17577236 0.78 GAA (0.35) TRIM58PLA2G2APLA2G4AGAAL3MBTL1
SCHEMBL13615950 0.77 MKNK1 (0.49) JAK2MAP4K4CDK4CCND1CDK2
SCHEMBL13615771 0.77 MKNK1 (0.49) JAK2MAP4K4CDK4CCND1CDK2
SCHEMBL13615921 0.77 MKNK1 (0.49) JAK2MAP4K4CDK4CCND1CDK2
SCHEMBL13556986 0.76 TRIM58 (0.41) TRIM58JAK2GAAL3MBTL1DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090273278-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090273278-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 TRIM58 4434/4885JAK2 4018/4885PLA2G2A 4111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.